Early Adoption of Biosimilar Growth Factors in Supportive Cancer Care

This retrospective observational analysis of health claims data compares the safety, effectiveness, and cost of biosimilar filgrastim and filgrastim.

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Chen, Xiaoxue, Agiro, Abiy, Barron, John, Debono, David, Fisch, Michael
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2018
Matèries:
Research Letter
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6440708/
https://ncbi.nlm.nih.gov/pubmed/30383135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.5090
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars